Home › Melanoma › Washington › Spokane
Melanoma clinical trials in Spokane, WA
5 studies for Melanoma are looking for participants at sites in and around Spokane (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RecruitingPhase 1
- Summit Cancer Center, Spokane
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Cancer Care Northwest - Spokane South, Spokane
- Cancer Care Northwest-Valley, Spokane
- Cancer Care Northwest-North Spokane, Spokane
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
RecruitingPhase 2
- USA07-0, Spokane
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RecruitingPhase 1/2
- Research Site 105, Spokane
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
About Melanoma
Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.
More about Melanoma on MedlinePlus
Melanoma trials in other cities
- Houston, TX61 studies
- New York City, NY41 studies
- Nashville, TN34 studies
- Los Angeles, CA34 studies
- Pittsburgh, PA31 studies
- Boston, MA25 studies
- St. Louis, MO23 studies
- Durham, NC22 studies
- Philadelphia, PA22 studies
- Tampa, FL21 studies
- Columbus, OH21 studies
- Dallas, TX21 studies
Other studies in Spokane
- Non-Small Cell Lung Cancer10 studies
- Breast Cancer8 studies
- Ovarian Cancer8 studies
- Colorectal Cancer8 studies
- Parkinson's Disease8 studies
- Prostate Cancer7 studies
- Cancer (all types)6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Chronic Lymphocytic Leukemia6 studies
- Triple-Negative Breast Cancer5 studies
- Geographic Atrophy5 studies
- Macular Degeneration5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.